15 нояб. 2023 г. · This is a new guideline, not an update of existing guidelines, with the exception of the section on hypertrophic cardiomyopathy (HCM), in which ...

3 нояб. 2016 г. · In clinical practice, the pathogenesis of heart failure (HF) has often been placed into 2 categories: ischemic and nonischemic cardiomyopathy.

... Cardiomyopathy, Hypokinetic Non-Dilated Cardiomyopathy ... the management of heart failure can be found in current ESC guidelines for chronic heart failure.

24 сент. 2024 г. · Updated and new recommendations cover select patients with HF and iron deficiency, anemia, coronary artery disease, AF, valvular heart disease, ...

Dilated cardiomyopathy is the third most common cause of heart failure and is the commonest type of cardiomyopathy (5). The phenotype of ventricular dilatation ...

18 мая 2019 г. · Dilated cardiomyopathy (DCM) is a frequent cause of heart failure (HF) and is characterized by dilation and impaired contraction of one or both ventricles.

25 авг. 2023 г. · This nomenclature prompts clinicians to consider cardiomyopathy as the cause of several clinical presentations (e.g. arrhythmia, heart failure), ...

Dilated cardiomyopathy (DCM) represents one of the most common causes of non-ischemic heart failure, characterised by ventricular dilation alongside systolic ...

15 сент. 2017 г. · Characteristics, treatments, and outcomes of hospitalized heart failure patients stratified by etiologies of cardiomyopathy. JACC Heart Fail.

30 авг. 2023 г. · Pharmacological treatment of dilated cardiomyopathy (DCM) patients does not differ from those recommended in chronic HF. SCD risk of DCM and ...